ストックスクリーナーアプリを入手
46.26
0.13%
0.06
アフターアワーズ：
46.14
-0.12
-0.26%
前日終値:
$46.20
開ける：
$46.19
24時間の取引高:
3.74M
Relative Volume:
0.81
時価総額：
$3.47B
収益：
-
当期純損益:
$-275.16M
株価収益率:
-11.89
EPS:
-3.89
ネットキャッシュフロー:
$-221.15M
1週間 パフォーマンス:
+0.06%
1か月 パフォーマンス:
+24.62%
6か月 パフォーマンス:
+36.10%
1年 パフォーマンス:
+7.71%
1日の値動き範囲:
$46.16
$46.26
1週間の範囲:
$46.10
$46.27
52週間の値動き範囲:
$28.21
$62.00
Springworks Therapeutics Inc Stock (SWTX) Company Profile
名前
Springworks Therapeutics Inc
セクター
電話
203-883-9490
住所
100 WASHINGTON BOULEVARD, STAMFORD, CT
SWTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
46.26 | 3.47B | 0 | -275.16M | -221.15M | -3.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-20 | 開始されました | Evercore ISI | Outperform |
| 2024-02-05 | 開始されました | Guggenheim | Buy |
| 2022-12-01 | 開始されました | BofA Securities | Buy |
| 2021-01-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-29 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-05 | 開始されました | Barclays | Overweight |
| 2020-03-19 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-01-21 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-04 | 開始されました | H.C. Wainwright | Buy |
| 2019-10-08 | 開始されました | Cowen | Outperform |
| 2019-10-08 | 開始されました | Goldman | Buy |
| 2019-10-08 | 開始されました | JP Morgan | Overweight |
| 2019-10-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Springworks Therapeutics Inc (SWTX) 最新ニュース
The Manufacturers Life Insurance Company Acquires 122,128 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Decoding SpringWorks Therapeutics Inc (SWTX): A Strategic SWOT I - GuruFocus
Duquesne Family Office LLC Buys 154,628 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq
SpringWorks Therapeutics: Q1 Earnings Snapshot - Greenwich Time
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Deep Track Capital LP - MarketBeat
ArrowMark Colorado Holdings LLC Boosts Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
The Pharma Letter M&A roundupApril 2025 - The Pharma Letter
Boxer Capital Management LLC Buys New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics Retail Chatter Spikes As Germany’s Merck Confirms Late-Stage Talks For $3.5B Buyout - MSN
Ally Bridge Group NY LLC Has $1.98 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Cut to Hold at Evercore ISI - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Earns "Neutral" Rating from HC Wainwright - MarketBeat
Soros Fund Management LLC Purchases 41,149 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
TD Cowen Reaffirms Hold Rating for SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
Merck KGaA (MKGAF) to Acquire SpringWorks Therapeutics for $3.9 Billion - GuruFocus
(SWTX) Trading Report - news.stocktradersdaily.com
Merck KGaA’s $3.9 Billion Springworks Deal to Boost US Presence - MSN
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap UpHere's Why - MarketBeat
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $63.17 - MarketBeat
Wedbush Reiterates "Neutral" Rating for SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Receives "Equal Weight" Rating from Barclays - MarketBeat
Price T Rowe Associates Inc. MD Sells 241,632 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Nebula Research & Development LLC - MarketBeat
SpringWorks Therapeutics’ (SWTX) “Neutral” Rating Reiterated at HC Wainwright - Defense World
Top Mid Cap Stocks Worth WatchingApril 28th - MarketBeat
Voya Investment Management LLC Acquires 67,559 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Taxation With Representation: Goodwin, Haynes Boone - Law360
Lord Abbett & CO. LLC Trims Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, SWTX on Behalf of Shareholders - marketscreener.com
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives $63.17 Consensus Price Target from Brokerages - Defense World
SpringWorks Therapeutics (NASDAQ:SWTX) Cut to “Hold” at Evercore ISI - Defense World
SpringWorks Therapeutics (SWTX) Downgraded Amid Acquisition Deal - GuruFocus
13,556 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Syon Capital LLC - MarketBeat
SPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc.SWTX - Business Wire
HC Wainwright Downgrades Springworks Therapeutics to Neutral From Buy, Adjusts Price Target to $47 From $74 - marketscreener.com
SpringWorks Therapeutics (SWTX) Downgraded by H.C. Wainwright Du - GuruFocus
SpringWorks Therapeutics (SWTX) Downgraded by H.C. Wainwright Due to Merck Deal | SWTX Stock News - GuruFocus
Merck KGaA Nears Deal to Buy SpringWorks Therapeutics - MSN
Springworks Therapeutics Inc (SWTX) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):